Article Details
Retrieved on: 2021-06-17 21:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On June 15, 2021, AzurRx BioPharma, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market, LLC ...
Article found on: marketexclusive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here